Go Pro
→ After KDA, PRE, and OCEAN—this is the one (From Crypto 101 Media) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
$6.66
+5.4%		$3.93
$1.31
▼
$10.75
$16.60M1.3875,704 shs52,781 shs
LianBio stock logo
LIAN
LianBio
$0.04
$0.07
$0.27
▼
$4.99
$4.32M0.231.04 million shs10,870 shs
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
$0.17
-34.4%		$0.33
$0.15
▼
$3.05
$16.42M0.121.28 million shs94.92 million shs
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
$3.60
-8.9%		$4.34
$1.11
▼
$17.50
$15.17M0.163,006 shs1,651 shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
+5.38%+17.05%+75.26%+201.36%-28.77%
LianBio stock logo
LIAN
LianBio
0.00%-18.37%-16.84%-71.22%-30.43%
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
-34.40%-36.33%-43.91%-51.29%-91.43%
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
-8.86%-15.69%-10.00%+18.03%-78.82%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
$6.66
+5.4%		$3.93
$1.31
▼
$10.75
$16.60M1.3875,704 shs52,781 shs
LianBio stock logo
LIAN
LianBio
$0.04
$0.07
$0.27
▼
$4.99
$4.32M0.231.04 million shs10,870 shs
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
$0.17
-34.4%		$0.33
$0.15
▼
$3.05
$16.42M0.121.28 million shs94.92 million shs
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
$3.60
-8.9%		$4.34
$1.11
▼
$17.50
$15.17M0.163,006 shs1,651 shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
+5.38%+17.05%+75.26%+201.36%-28.77%
LianBio stock logo
LIAN
LianBio
0.00%-18.37%-16.84%-71.22%-30.43%
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
-34.40%-36.33%-43.91%-51.29%-91.43%
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
-8.86%-15.69%-10.00%+18.03%-78.82%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
2.40
Hold$15.63134.61% Upside
LianBio stock logo
LIAN
LianBio
0.00
N/AN/AN/A
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
2.40
Hold$9.005,178.59% Upside
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest LIAN, ZIVO, MDCX, and ADIL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/17/2026
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
Alliance Global Partners logo
Alliance Global Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
8/3/2026
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
Alliance Global Partners logo
Alliance Global Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$11.00
7/28/2026
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
Alliance Global Partners logo
Alliance Global Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy
7/17/2026
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/8/2026
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
6/15/2026
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
Loop Capital logo
Loop Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$6.00
6/15/2026
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy
6/11/2026
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
Brookline Capital Markets logo
Brookline Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
(Data available from 9/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
N/AN/AN/AN/A($14.61) per shareN/A
LianBio stock logo
LIAN
LianBio
N/AN/AN/AN/A$2.71 per shareN/A
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
N/AN/AN/AN/A($0.03) per shareN/A
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
$15.85K957.35N/AN/A($0.81) per share-4.44
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
-$7.98M-$14.73N/AN/AN/AN/A-203.87%-512.41%11/18/2026 (Estimated)
LianBio stock logo
LIAN
LianBio
-$110.29M-$0.81N/AN/AN/AN/A-33.17%-30.19%N/A
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
-$35.46M-$2.46N/AN/AN/AN/A-3,137.84%-263.24%11/13/2026 (Estimated)
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
-$7.78M-$1.40N/AN/AN/AN/AN/A-2,240.92%N/A

Latest LIAN, ZIVO, MDCX, and ADIL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
-$1.0325-$11.25-$10.2175-$11.25N/AN/A
8/12/2026Q2 2026
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
-$0.1275-$0.21-$0.0825-$0.21N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
N/AN/AN/AN/AN/A
LianBio stock logo
LIAN
LianBio
N/AN/AN/AN/AN/A
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
N/AN/AN/AN/AN/A
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
N/A
5.63
5.63
LianBio stock logo
LIAN
LianBio
N/A
10.06
10.06
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
N/A
1.57
1.57
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
N/A
0.17
0.17

Institutional Ownership

CompanyInstitutional Ownership
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
16.41%
LianBio stock logo
LIAN
LianBio
74.85%
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
N/A
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
12.83%

Insider Ownership

CompanyInsider Ownership
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
8.00%
LianBio stock logo
LIAN
LianBio
7.59%
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
8.10%
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
48.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
202.63 million2.42 millionNo Data
LianBio stock logo
LIAN
LianBio
110108.06 million99.86 millionNot Optionable
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
N/A63.18 million58.06 millionN/A
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
104.22 million2.91 millionNot Optionable

Recent News About These Companies

Zivo Bioscience, Inc. Announces Transition to OTCID Marketplace
May 12, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260512411739/en/zivo-bioscience-inc.-announces-transition-to-otcid-marketplace/
Zivo Bioscience Inc. Wt
April 11, 2026  |  barrons.comhttps://www.barrons.com/market-data/stocks/zivow
ZIVO Bioscience Provides Special Letter to Shareholders
March 27, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260327190358/en/ZIVO-Bioscience-Provides-Special-Letter-to-Shareholders/
Maxim Group Reaffirms Their Hold Rating on Zivo Bioscience (ZIVO)
December 15, 2025  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/ZIVO/pressreleases/36474537/maxim-group-reaffirms-their-hold-rating-on-zivo-bioscience-zivo/
ZIVO Bioscience releases letter to shareholders
September 14, 2025  |  wattagnet.comW
ZIVO Bioscience CEO Letter to Shareholders Highlights Progress with Human Nutrition and Animal Therapeutic Businesses
September 10, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250910182550/en/zivo-bioscience-ceo-letter-to-shareholders-highlights-progress-with-human-nutrition-and-animal-therapeutic-businesses/
ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO's Immune-Enhancing Compounds in Poultry
June 20, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250620564330/en/zivo-bioscience-and-leading-global-animal-health-company-to-advance-zivo%e2%80%99s-immune-enhancing-compounds-in-poultry/
University of Delaware Study Identifies Optimal Formulation of ZIVO’s Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry
May 7, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/university-delaware-study-identifies-optimal-215400486.html
University of Delaware Study Identifies Optimal Formulation of ZIVO's Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry
May 6, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250506414477/en/university-of-delaware-study-identifies-optimal-formulation-of-zivo%e2%80%99s-active-ingredients-for-further-testing-to-mitigate-avian-influenza-in-poultry/
ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry
February 6, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250206639313/en/zivo-bioscience-plans-new-study-with-university-of-delaware-to-combat-avian-influenza-in-poultry/
Zivo Bioscience issues new shares, raises $1.5 million
January 28, 2025  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/zivo-bioscience-issues-new-shares-raises-1-5-million/ar-AA1xZjTM
Tuesday's Insider Activity: Top Buys and Sells in US Stocks Revealed
January 1, 2025  |  investing.comhttps://www.investing.com/news/stock-market-news/tuesdays-insider-activity-top-buys-and-sells-in-us-stocks-revealed-93CH-3793355
ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza
December 20, 2024  |  businesswire.comhttps://www.businesswire.com/news/home/20241220941955/en/ZIVO-Bioscience-Reports-Preliminary-Efficacy-of-its-Proprietary-Active-Ingredients-in-the-Battle-Against-Avian-Influenza/
ZIVO Stock Earnings: Zivo Bioscience Reported Results for Q4 2023
March 18, 2024  |  investorplace.comhttps://investorplace.com/earning-results/2024/03/zivo-stock-earnings-zivo-bioscience-for-q4-of-2023/?utm_source=marketbeat&utm_medium=referral
Harmony Biosciences Holdings
March 4, 2024  |  forbes.comhttps://www.forbes.com/companies/harmony-biosciences-holdings/
Regencell Bioscience Holdings Ltd RGC
February 1, 2024  |  morningstar.comM
ZIVO Bioscience Announces Uplisting to OTCQB Market
January 29, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/zivo-bioscience-announces-uplisting-otcqb-130000877.html?.tsrc=rss
Ideaya Biosciences
January 18, 2024  |  forbes.comhttps://www.forbes.com/companies/ideaya-biosciences/
Dare Bioscience Inc DARE
January 14, 2024  |  morningstar.comM
Zivo Bioscience Inc (ZIVO) USD0.001
November 11, 2023  |  hl.co.ukhttps://www.hl.co.uk/shares/shares-search-results/z/zivo-bioscience-inc-usd1.001/costs

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Microsoft logo and sign displayed in the lobby of a corporate office building with a glass meeting room.
Microsoft's Maia 300 Chip Targets NVIDIA's AI Dominance
By Chris Markoch | August 16, 2026
Tablet displaying an interest rate chart on a desk, with the Federal Reserve building visible through a window.
3 Companies That Could Thrive While the Fed Holds Rates Steady
By Nathan Reiff | August 11, 2026
Datavault logo displayed in front of an open bank vault door within a server room lined with data streams.
Datavault AI Locks Down CyberCatch in $94M Security Rollup
By Jeffrey Neal Johnson | August 19, 2026
A stylized computer chip labeled ETF surrounded by glowing circuit board lines and digital blocks.
Why These 3 Equal Weight ETFs Have Outperformed the S&P This Year
By Nathan Reiff | August 8, 2026
Illuminated Nasdaq logo displayed on a glass building facade, with city skyscrapers reflected around it.
Nasdaq’s 23-Hour Trading Push Could Turn Global Liquidity Into a Growth Engine
By Jeffrey Neal Johnson | August 20, 2026
Adial Pharmaceuticals stock logo

Adial Pharmaceuticals NASDAQ:ADIL

$6.66 +0.34 (+5.38%)
Closing price 09/3/2026 04:00 PM Eastern
Extended Trading
$6.44 -0.22 (-3.29%)
As of 07:33 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.

LianBio stock logo

LianBio NASDAQ:LIAN

$0.04 0.00 (0.00%)
As of 09/2/2026

LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex blepharitis and meibomian gland disease; NBTXR3 for the treatment of head and neck squamous cell carcinoma, and solid tumor; Infigratinib for the treatment of second-line and first-line cholangiocarcinoma, and gastric cancers; BBP-398 for solid tumors; Omilancor and NX-13 for ulcerative colitis and Crohn's disease; LYR-210 for chronic rhinosinusitis; and Sisunatovir for respiratory syncytical virus. It has a partnership with Tarsus Pharmaceuticals, Inc. to develop and commercialize TP-03 for the treatment of Demodex blepharitis; and Nanobiotix S.A. to develop and commercialize NBTXR3, a radioenhancer designed to be injected directly into a malignant tumor prior to standard radiotherapy. The company was incorporated in 2019 and is headquartered in Princeton, New Jersey.

Medicus Pharma stock logo

Medicus Pharma NASDAQ:MDCX

$0.17 -0.09 (-34.40%)
Closing price 09/3/2026 04:00 PM Eastern
Extended Trading
$0.16 -0.01 (-4.40%)
As of 07:41 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.

ZIVO Bioscience stock logo

ZIVO Bioscience NASDAQ:ZIVO

$3.60 -0.35 (-8.86%)
As of 09/3/2026 03:39 PM Eastern

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas